Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryBreast tomosynthesis AI detection software from Hologic for highlighting suspicious lesions and supporting radiologist review.
Breast imaging programs already standardized on Hologic 3D mammography that need product-specific FDA and workflow review for CAD support.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Hologic Genius AI Detection as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Match the installed version to the correct FDA 510(k), product code, compatible Hologic systems, and intended use before applying case scores or markers clinically. |
|---|---|
| Privacy | Review whether images, case scores, logs, support data, or remote-service access leave the facility, and confirm retention, access-control, audit, and contract terms. |
| Evidence | Evaluate reader-study evidence and local monitoring for cancer detection, recall, breast-density mix, false markers, missed cancers, and effects on radiologist workload. |
| Workflow | Best governed as radiologist-reviewed breast-screening CAD support where AI marks and case scores inform but do not replace final interpretation. |
Hologic describes Genius AI Detection as deep-learning software for breast tomosynthesis lesion detection, and FDA records list Hologic Genius AI Detection 2.0 clearances including K221449, K230096, and K243341 under radiological computer assisted detection or diagnosis software.
Not for: Autonomous breast-cancer diagnosis, unsupported mammography systems, or treating older and newer Genius AI Detection clearances as interchangeable.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.